CMS Proposes Rule to Accelerate Prior Authorization for Prescription Drugs in Medicaid and CHIP

• A new VCU Health study indicates alcohol-related liver disease prevalence may be twice as high as previously estimated because of underreported alcohol consumption. • The research uncovers hidden scale of liver damage, challenging prior data on this growing public health issue. • Findings highlight need for better screening and awareness amid rising alcohol use disorders in the US.

• Thomas Jefferson University launched a multicenter clinical trial led by Manisha Verma, MD, and Victor Navarro, MD, at Jefferson Einstein Philadelphia Hospital to improve palliative care for advanced liver disease patients. • Advanced liver disease causes significant scarring and loss of function, leading to serious health challenges with limited quality-of-life support. • Funded by the Patient-Centered Outcomes Research Institute and published in JAMA Internal Medicine, the trial addresses a major care gap for ALD patients nationwide.

• The American College of Emergency Physicians reports a record 3,058 positions filled in emergency medicine residencies, signaling rebound from pandemic-era lows. • More applicants matched into emergency medicine than ever before, as of March 18, 2026. • This surge addresses physician shortages in high-demand ERs across US hospitals.

• A Fred Hutch Cancer Center graduate student presented over 25,000 measurements of influenza-fighting antibodies to WHO scientists via videoconference last fall. • The dataset, published in Virus Evolution, offers near real-time tracking of human immune responses to current flu strains, improving seasonal vaccine composition. • This method addresses gaps in traditional surveillance, potentially enhancing vaccine effectiveness against evolving viruses.

• The US measles case count increased by 43 cases last week to 1,714 total, according to the CDC's weekly update released April 10, 2026. • More than half of the new cases occurred in Utah, marking a smaller jump compared to the prior week's 96-case increase. • This ongoing outbreak highlights gaps in vaccination coverage amid public health concerns over declining immunization rates.

• CDC data reveals sexually transmitted disease rates fell among US adults last year, but congenital syphilis in newborns kept increasing. • This trend highlights persistent challenges in prenatal screening and treatment access for at-risk pregnant women. • Rising newborn syphilis threatens infant health outcomes, prompting calls for enhanced public health interventions.

• The COVID-19 variant BA.3.2, nicknamed 'Cicada,' has spread to half the US states and at least 23 countries worldwide. • Health monitors track its emergence amid ongoing circulation of respiratory pathogens. • While specific severity data is pending, it adds to concerns over variant evolution and vaccine effectiveness.

• Influenza cases are peaking for a second time this season, with at least 41 states reporting high or very high flu activity. • This surge coincides with ongoing respiratory illness pressures documented by health authorities. • Increased hospitalizations strain healthcare systems, particularly affecting unvaccinated children and adults.

• The CDC has suspended dozens of diagnostic tests as part of agency downsizing, disrupting testing capabilities for critical infectious diseases including rabies and mpox. • The testing pause has left pharmacists and state health departments scrambling to identify alternative diagnostic pathways and coordinate emergency responses. • Public health officials and pharmacy professionals have raised alarms about the implications for disease surveillance, outbreak detection, and timely clinical decision-making.

• FDA has approved an investigational new drug application for synthetic CAR-T (sCAR-T) therapy targeting autoimmune conditions. • The clearance enables clinical trials to test this engineered cell therapy in US patients with refractory autoimmune diseases. • sCAR-T represents a novel approach adapting cancer immunotherapy for immune disorders, potentially offering durable remissions.

• The CDC reported 43 new measles cases in the US for the week ending April 10, 2026, bringing the national total to 1,714 cases. • More than half of the new cases occurred in Utah, which saw 73 infections last week alone after 142 cases in the past three weeks versus 197 for all of 2025. • The slower increase compared to the prior week's 96 cases highlights ongoing outbreaks concentrated in specific states amid declining vaccination rates.